MoneyWorks4Me

The Revenue for the quarter ended  June 2023 of Rs. 1356.19 millions grew by 9.84 % from Rs. 1234.71 millions.A good growth in profit of 26.64% reported to Rs. 190.13  millions over Rs. 150.13 millions of corresponding previous quarter.Operating profit surged to 284.06 millions from the corresponding previous quarter of 234.07 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1356.19 1234.71 9.84 1356.19 1234.71 9.84 5103.09 4720.79 8.10
Other Income 76.91 64.95 18.41 76.91 64.95 18.41 224.84 99.98 124.88
PBIDT 284.06 234.07 21.36 284.06 234.07 21.36 1116.50 1054.68 5.86
Interest 4.15 4.11 0.97 4.15 4.11 0.97 20.29 14.51 39.83
PBDT 279.91 229.96 21.72 279.91 229.96 21.72 1096.21 1040.17 5.39
Depreciation 25.45 20.69 23.01 25.45 20.69 23.01 91.66 80.88 13.33
PBT 254.46 209.27 21.59 254.46 209.27 21.59 1004.55 959.29 4.72
TAX 64.33 59.14 8.78 64.33 59.14 8.78 275.56 265.74 3.70
Deferred Tax 9.23 -0.26 -3650.00 9.23 -0.26 -3650.00 15.86 7.20 120.28
PAT 190.13 150.13 26.64 190.13 150.13 26.64 728.99 693.55 5.11
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 20.95 18.96 10.49 20.95 18.96 10.49 21.88 22.34 -2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..